Use of dairy products, lactose, and calcium and risk of ovarian cancer – Results from a Danish case-control study

References

• Karim-Kos HE, de VE, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW. Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008;44: 1345–89.
   PubMed Web of Science ®Google Scholar
• Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint Å, . NORDCAN: Cancer Incidence, Mortality, Prevalence and Prediction in the Nordic Countries, Version 3.6. 2010. Association of the Nordic Cancer Registries. Danish Cancer Society.
   Google Scholar
• Cramer DW. Lactase persistence and milk consumption as determinants of ovarian cancer risk. Am J Epidemiol 1989; 130:904–10.
   PubMed Web of Science ®Google Scholar
• Larsson SC, Bergkvist L, Wolk A. Milk and lactose intakes and ovarian cancer risk in the Swedish Mammography Cohort. Am J Clin Nutr 2004;80:1353–7.
   PubMed Web of Science ®Google Scholar
• Larsson SC, Orsini N, Wolk A. Milk, milk products and lactose intake and ovarian cancer risk: A meta-analysis of epidemiological studies. Int J Cancer 2006;118:431–41.
   PubMed Web of Science ®Google Scholar
• Genkinger JM, Hunter DJ, Spiegelman D, Anderson KE, Arslan A, Beeson WL, . Dairy products and ovarian cancer: A pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev 2006;15:364–72.
   PubMed Web of Science ®Google Scholar
• Mommers M, Schouten LJ, Goldbohm RA, van den Brandt PA. Dairy consumption and ovarian cancer risk in the Netherlands Cohort Study on Diet and Cancer. Br J Cancer 2006;94:165–70.
   PubMed Web of Science ®Google Scholar
• Qin LQ, Xu JY, Wang PY, Hashi A, Hoshi K, Sato A. Milk/dairy products consumption, galactose metabolism and ovarian cancer: Meta-analysis of epidemiological studies. Eur J Cancer Prev 2005;14:13–9.
   PubMed Web of Science ®Google Scholar
• Goodman MT, Wu AH, Tung KH, McDuffie K, Kolonel LN, Nomura AM, . Association of dairy products, lactose, and calcium with the risk of ovarian cancer. Am J Epidemiol 2002;156:148–57.
   PubMed Web of Science ®Google Scholar
• Koralek DO, Bertone-Johnson ER, Leitzmann MF, Sturgeon SR, Lacey JV, Jr., Schairer C, . Relationship between calcium, lactose, vitamin D, and dairy products and ovarian cancer. Nutr Cancer 2006;56:22–30.
   PubMed Web of Science ®Google Scholar
• Webb PM, Bain CJ, Purdie DM, Harvey PW, Green A. Milk consumption, galactose metabolism and ovarian cancer (Australia). Cancer Causes Control 1998;9:637–44.
   PubMed Web of Science ®Google Scholar
• Gallus S, Bravi F, Talamini R, Negri E, Montella M, Ramazzotti V, . Milk, dairy products and cancer risk (Italy). Cancer Causes Control 2006;17:429–37.
   PubMed Web of Science ®Google Scholar
• Fairfield KM, Hunter DJ, Colditz GA, Fuchs CS, Cramer DW, Speizer FE, . A prospective study of dietary lactose and ovarian cancer. Int J Cancer 2004;110:271–7.
   PubMed Web of Science ®Google Scholar
• Kushi LH, Mink PJ, Folsom AR, Anderson KE, Zheng W, Lazovich D, . Prospective study of diet and ovarian cancer. Am J Epidemiol 1999;149:21–31.
   PubMed Web of Science ®Google Scholar
• Cramer DW, Greenberg ER, Titus-Ernstoff L, Liberman RF, Welch WR, Li E, . A case-control study of galactose consumption and metabolism in relation to ovarian cancer. Cancer Epidemiol Biomarkers Prev 2000;9:95–101.
   PubMed Web of Science ®Google Scholar
• Bosetti C, Negri E, Franceschi S, Pelucchi C, Talamini R, Montella M, . Diet and ovarian cancer risk: A case-control study in Italy. Int J Cancer 2001;93:911–5.
   PubMed Web of Science ®Google Scholar
• Cramer DW, Harlow BL, Willett WC, Welch WR, Bell DA, Scully RE, . Galactose consumption and metabolism in relation to the risk of ovarian cancer. Lancet 1989; 2:66–71.
   PubMed Web of Science ®Google Scholar
• Risch HA, Jain M, Marrett LD, Howe GR. Dietary lactose intake, lactose intolerance, and the risk of epithelial ovarian cancer in southern Ontario (Canada). Cancer Causes Control 1994;5:540–8.
   PubMed Web of Science ®Google Scholar
• Kiani F, Knutsen S, Singh P, Ursin G, Fraser G. Dietary risk factors for ovarian cancer: The Adventist Health Study (United States). Cancer Causes Control 2006;17: 137–46.
   PubMed Web of Science ®Google Scholar
• Glud E, Kjaer SK, Thomsen BL, Hogdall C, Christensen L, Hogdall E, . Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer. Arch Intern Med 2004;164:2253–9.
   PubMed Web of Science ®Google Scholar
• Gjerstorff ML. The Danish cancer registry. Scand J Public Health 2011;39(Suppl):42–5.
   PubMed Web of Science ®Google Scholar
• Danish Food Composition Databank [Internet]. Version 7.01. [cited 2010 Oct 26]. Available from: http://www. foodcomp.dk/.
   Google Scholar
• Danish Dairy Board. Dairy Statistics 2007. 2008.
   Google Scholar
• Danish Veterinary and Food Administration. Forsyningen af fødevarer 1955–1999 [Supply of foods 1955–1999] (in Danish). 2001.
   Google Scholar
• Chen YT, Mattison DR, Feigenbaum L, Fukui H, Schulman JD. Reduction in oocyte number following prenatal exposure to a diet high in galactose. Science 1981;214:1145–7.
   PubMed Web of Science ®Google Scholar
• Swartz WJ, Mattison DR. Galactose inhibition of ovulation in mice. Fertil Steril 1988;49:522–6.
   PubMed Web of Science ®Google Scholar
• Jiang F, Bao J, Li P, Nicosia SV, Bai W. Induction of ovarian cancer cell apoptosis by 1,25-dihydroxyvitamin D3 through the down-regulation of telomerase. J Biol Chem 2004;279: 53213–21.
   PubMed Web of Science ®Google Scholar
• McCarty MF. Parathyroid hormone may be a cancer promoter – an explanation for the decrease in cancer risk associated with ultraviolet light, calcium, and vitamin D. Med Hypotheses 2000;54:475–82.
   PubMed Web of Science ®Google Scholar
• Langdon SP, Hawkes MM, Lawrie SS, Hawkins RA, Tesdale AL, Crew AJ, . Oestrogen receptor expression and the effects of oestrogen and tamoxifen on the growth of human ovarian carcinoma cell lines. Br J Cancer 1990; 62:213–6.
   PubMed Web of Science ®Google Scholar